In most realms of commerce, if a product fails to deliver what’s been promised, consumers are financially covered through refunds and warranties. This has never been the case with pharmaceuticals and medical devices. Increasingly, however, that’s going to change.

In her recent article for STAT, Money-Back Guarantee: The New Trend in Drug and Device Marketing, Rita Numerof presents examples of manufacturers putting payment for their products at risk based on performance and discusses what’s led to this change.